[Zinc deficiency syndrome as a side effect of chelating agents].
Zinc deficiency syndrome with acrodermatitis enteropathica-like skin changes developed in a 66-year-old patient during treatment of manganese poisoning with the chelating agents CaNa2-EDTA and Ca-trisodium-pentetate, which had reduced the serum-zinc level. The skin changes cleared up after oral administration of zinc aspartate.
D000169:Acrodermatitis / Q000139:chemically induced / Q000188:drug therapy; D000368:Aged; D001224:Aspartic Acid / Q000627:therapeutic use; D002614:Chelating Agents / Q000009:adverse effects* / Q000627:therapeutic use; D004492:Edetic Acid / Q000627:therapeutic use; D006801:Humans; D008297:Male; D020149:Manganese Poisoning; D015032:Zinc / Q000172:deficiency*
D002614:Chelating Agents; D001224:Aspartic Acid; D004492:Edetic Acid; D015032:Zinc
Zinkmangelsyndrom als Nebenwirkung von Chelatbildnern.